Study Description and Background
Few evidence-based treatment options exist for patients with posttraumatic stress disorder (PTSD) inadequately responsive to standard medication treatments, such as treatment with serotonin specific reuptake inhibitors (SSRIs).
Although many agents have been studied in the management of PTSD, treatment augmentation with lithium remains almost wholly unexplored. Potential benefits of lithium include a broad clinical utility; reported clinical benefits for aggression, suicidality, and mood; and positive effects on brain areas that can be affected by PTSD.
Recent estimates suggest that 14% of Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) service members will suffer from symptoms of PTSD.1 Since 1997, the average annual growth in all users of VA specialty mental health services has averaged 37,000 Veterans per year, including 22,000 per year with PTSD.2 There is a clear need to better characterize PTSD refractory to standard treatments and to expand the therapeutic arsenal available to patients and clinicians managing this disorder.
References
- Tanielian T, Jaycox, LH, eds. Invisible wounds of war: Psychological and cognitive injuries, their consequences, and services to assist recovery. Santa Monica, CA: RAND Corp.; 2008
- Rosenheck RA, Fontana AF. Recent trends In VA treatment of posttraumatic stress disorder and other mental disorders. Health Aff (Millwood) 2007;26:1720-7.